Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide vs. furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial). (Q47644833)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 September 2017

Language	Label	Description	Also known as
English	Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide vs. furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).	scientific article published on 11 September 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide vs. furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial). (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

1 reference

based on heuristic

inferred from title

Heart failure with preserved ejection fraction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

object named as

Susana Ravassa

12

0 references

13

object named as

Burkert Pieske

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

Carsten Tschöpe

17

object named as

Carsten Tschöpe

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Sophie Van Linthout

2

object named as

Sophie Van Linthout

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Frank Spillmann

9

object named as

Frank Spillmann

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Dirk Westermann

3

object named as

Dirk Westermann

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

8

object named as

Mario Kasner

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Ruhdja Lindhorst

4

object named as

Ruhdja Lindhorst

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

7

object named as

Anna Bobenko

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

author name string

Tobias Daniel Trippel

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Anja Sandek

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Stefanie Ernst

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Arantxa González

10

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Begoña López

11

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Walter J Paulus

14

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Javier Díez

15

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Frank Edelmann

16

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

publication date

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Trends in prevalence and outcome of heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Role of left ventricular stiffness in heart failure with normal ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Myocardial fibrosis: functional significance and regulatory factors

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Circulating biomarkers of collagen metabolism in cardiac diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure: potential role of lysyl oxidase

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Extracellular matrix fibrotic markers in heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Serum carboxy-terminal propeptide of type I procollagen (PIP) is a marker of diastolic dysfunction in patients with early type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Torasemide in chronic heart failure: results of the TORIC study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Effects of Torasemide on Left Ventricular Function and Neurohumoral Factors in Patients With Chronic Heart Failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

"One Size Does Not Fit All": How to Individualize Decongestive Therapy Strategies in Heart Failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Phenomapping for novel classification of heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Heart Failure with Preserved Ejection Fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Spironolactone for heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Post-translational modification of bone morphogenetic protein-1 is required for secretion and stability of the protein

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Filling Pressures and Collagen Metabolism in Hypertensive Patients With Heart Failure and Normal Ejection Fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Diastolic Stiffness of the Failing Diabetic Heart

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

21 January 2018

Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

7 January 2021

based on heuristic

inferred from DOI database lookup

Propeptide of procollagen type I (PIP) and outcomes in decompensated heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

7 January 2021

based on heuristic

inferred from DOI database lookup

Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

7 January 2021

based on heuristic

inferred from DOI database lookup

The cardiac atria are chambers of active remodeling and dynamic collagen turnover during evolving heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.960

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJHF.960

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/28891228

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47644833&oldid=1866824096"